tm logo
PRODIGY BIOTECH
FORMALIZED

on 20 Oct 2023

Last Applicant/ Owned by

PRODIGY BIOTECH INC.

719 Bradford TerraceWest Chester, PA 19382

US

Serial Number

2288322 filed on 20th Oct 2023

Correspondent Address

World Exchange Plaza100 Queen Street, Suite 1300Ottawa

ONTARIO

CA

K1P1J9

PRODIGY BIOTECH

Trademark usage description

pharmaceutical preparations in the nature of igy antibodies, avian hyperimmune egg product and avian hyperimmune egg yolk product for therapeutics and Read More

Classification Information


Class [005]
Pharmaceutical preparations in the nature of IgY antibodies, avian hyperimmune egg product and avian hyperimmune egg yolk product for therapeutics and prophylactic use for humans and animals and for use in aquaculture; pharmaceutical preparations in the nature of IgY antibodies, avian hyperimmune egg product and avian hyperimmune egg yolk product, namely, antibacterial treatments, anti-toxin treatments, anti-fungal treatments, anti-yeast treatments, anti-parasite treatments, anti-cytokine treatments, anti-receptor treatments, antibiotic treatments and antiviral treatments, for humans and animals and for use in aquaculture; pharmaceutical preparations in the nature of IgY antibodies, avian hyperimmune egg product and avian hyperimmune egg yolk product for repairing, modifying and modulating the intestinal microbiome; pharmaceutical and biological preparations for repairing, modifying and modulating the intestinal microbiome; preparations and substances for pharmaceutical and medical purposes, namely, for the treatment of gut dysbioses, inflammatory disorders and conditions, gastrointestinal diseases and disorders, gastrointestinal injury conditions, and digestive abnormalities; pharmaceutical and therapeutic preparations for use in the prevention and treatment of abnormalities in the human gut microbiome and gastrointestinal health; pharmaceutical preparations for medical, veterinary and aquaculture purposes, namely, antibacterial treatments, anti-toxin treatments, antibiotic treatments and antiviral treatments


Classification kind code

12

Mark Details


Serial Number

2288322

Mark Type

Trademark

Legal History


Action TakenStatus
Submitted for opposition 287
on 02th Nov 2023
Pre-Assessment Letter Sent
Submitted for opposition 30
on 20th Oct 2023
Filed
Submitted for opposition 1
on 20th Oct 2023
Created
Submitted for opposition 31
on 20th Oct 2023
Formalized